M&G Investment Management LTD Biocryst Pharmaceuticals Inc Transaction History

M&G Investment Management LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$11.18 - $15.46 $781,895 - $1.08 Million	-69,937 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$14.21 - $17.65 $152,814 - $189,808	10,754 Added 18.17%	69,937 $1 Million
Q2 2021 Aug 16, 2021	BUY	$9.5 - $17.24 $562,238 - $1.02 Million	59,183 New	59,183 $947,000

257

173M

397K

444K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.47B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on M&G Investment Management LTD with notifications on news.